Europe Diagnostic Controls Market is expected to grow with the CAGR of 8.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-molecular-diagnostic-controls-market
Europe diagnostic controls market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Europe diagnostic controls market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
For instance,
- In June 2021, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market.
Bio-Rad Laboratories Inc. is a dominating player in Europe Diagnostic controls market. The other key players existing in the market includes Randox Lanoratories Ltd., Technopath Clinical Diagnostics, Thermo Fisher Scientific Inc., Abbott, and bioMérieux SA among others.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. has it base headquarters in California, U.S. and was founded in 1952. The company is focused in development, manufacturing, and marketing of broad range of innovative product for the life science research and clinical diagnostics market. The company deals in two business segment life science and clinical diagnostic. The company deals in Product portfolio such as life science research, clinical diagnostics, process separators and food science out of which clinical diagnostics is the market focused product portfolio.
- In June, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market.
The company has presence in North America, Latin America, Europe, Asia-Pacific. The company has its base subsidiaries in Bio-Rad Korea (Korea), Bio-Rad laboratories S.r.l. (Italy), Bio-Rad S.A (Canada), Bio-Rad Laboratories GmbH (Germany), Bio-Rad Laboratories (India) among others.
Randox Laboratories Ltd.
Randox Laboratories Ltd. is headquartered in Antrim, U.K. and was founded in 1982. The company is focused on the development of prioneering tests for a range of common illness such as cancer, cardiovascular disease and alzheimer’s disease. The company has multiple product categories such as clinical chemistry, analysers, molecular, reagents, quality control, EQA, Veterinary, immunoassay, biosciences and disease markers out of which quality control are the market focused category.
- In March, Randox Laboratories Ltd. announced that it has launched new product named ACUSERA D-Dimer Control. This new product launched by the company has increased its sales and demand in the market leading to increased revenue in future.
The company has wide global presence across America, Europe.
Technopath Clinical Diagnostics
Technopath clinical diagnostics is headquartered in Tipperary, Ireland and was founded in 2004. The company is engaged in the development and manufacturing of quality control material and software for clinical laboratories. The company offers wide range of product categories such as quality control materials, informatics solutions and other products. The market focused category is quality control materials.
- In February, Technopath Clinical Diagnostics announced that it has been acquired by the company named LGC. This acquisition done by the company has strengthened its position in the clinical diagnostics QC market
The company has wide global presence across the world in Americas, Europe.
